BACKGROUND: In patients with colorectal liver metastases (CLM) R0 resection significantly improves overall survival (OS). METHODS: In this report, we present the results of a phase II trial of FOLFOX6+bevacizumab in patients with non-optimally resectable CLM. Patients received six cycles of FOLFOX6+ five of bevacizumab. Patients not achieving resectability received six additional cycles of each. A PET-CT was performed at baseline and again within 1 month after initiating treatment. RESULTS: From September 2005 to July 2009, 21 patients were enrolled (Male/Female: 15/6; median age: 65 years). An objective response (OR) was documented in 12 cases (57.1%; complete responses (CRs): 3, partial response (PR): 9); one patient died from toxicity before surgery. Thirteen patients underwent radical surgery (61.9%). Three (23%) had a pathological CR (pCR). Six patients (46.1%) experienced minor postsurgical complications. After a median 38.8-month follow-up, the median OS was 22.5 months. Patients achieving at least 1 unit reduction in Standard uptake value (SUV)max on PET-CT had longer progression-free survival (PFS) (median PFS: 22 vs 14 months, P=0.001). CONCLUSIONS: FOLFOX6+bevacizumab does not increase postsurgical complications, yields high rates of resectability and pCR. Early changes in PET-CT seem to be predictive of longer PFS.
|Data di pubblicazione:||2011|
|Titolo:||FOLFOX6 and bevacizumab in non-optimally resectable liver metastases from colorectal cancer.|
|Autore/i:||Bertolini, F; Malavasi, N; Scarabelli, L; Fiocchi, F; Bagni, B; Del Giovane, C; Colucci, G; Gerunda, Ge; Depenni, R; Zironi, S; Fontana, A; Pettorelli, E; Luppi, G; Conte, Pf|
|Digital Object Identifier (DOI):||10.1038/bjc.2011.43. Epub 2011 Mar 8.|
|Codice identificativo ISI:||WOS:000288938100005|
|Codice identificativo Scopus:||2-s2.0-79953191763|
|Codice identificativo Pubmed:||21386839|
|Citazione:||FOLFOX6 and bevacizumab in non-optimally resectable liver metastases from colorectal cancer / Bertolini, F; Malavasi, N; Scarabelli, L; Fiocchi, F; Bagni, B; Del Giovane, C; Colucci, G; Gerunda, Ge; Depenni, R; Zironi, S; Fontana, A; Pettorelli, E; Luppi, G; Conte, Pf. - In: BRITISH JOURNAL OF CANCER. - ISSN 1532-1827. - STAMPA. - 104(2011), pp. 1079-1084.|
|Tipologia||Articolo su rivista|
File in questo prodotto:
I documenti presenti in Iris Unimore sono rilasciati con licenza Creative Commons Attribuzione - Non commerciale - Non opere derivate 3.0 Italia, salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris